EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biosensing of Alpha-Fetoprotein: A Key Direction toward the Early Detection and Management of Hepatocellular Carcinoma

Lohit Ramachandran, Farah Abul Rub, Amro Hajja, Ibrahim Alodhaibi, Momo Arai iD, Mohammed Alfuwais, Tariq Makhzoum iD, Ahmed Yaqinuddin iD, Khaled Al-Kattan iD, Abdullah M Assiri iD, Dieter C Broering, Raja Chinnappan iD und 2 weitere

Biosensors · 2024

DOI: 10.3390/bios14050235 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors, 2024. Verfasst von Lohit Ramachandran und 13 weiteren Autor:innen. Beteiligte Einrichtung: Microfluidics, Sensors and Diagnostics (μSenD) Laboratory, Centre for Microfluidics, Biomarkers, Photoceutics and Sensors (μBioPS), Department of Bio…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, alpha-Fetoproteins, Liver Neoplasms, Biosensing Techniques. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is currently one of the most prevalent cancers worldwide. Associated risk factors include, but are not limited to, cirrhosis and underlying liver diseases, including chronic hepatitis B or C infections, excessive alcohol consumption, nonalcoholic fatty liver disease (NAFLD), and exposure to chemical carcinogens. It is crucial to detect this disease early on before it metastasizes to adjoining parts of the body, worsening the prognosis. Serum biomarkers have proven to be a more accurate diagnostic tool compared to imaging. Among various markers such as nucleic acids, circulating genetic material, proteins, enzymes, and other metabolites, alpha-fetoprotein (AFP) is a protein marker primarily used to diagnose HCC. However, current methods need a large sample and carry a high cost, among other challenges, which can be improved using biosensing technology. Early and accurate detection of AFP can prevent severe progression of the disease and ensure better management of HCC patients. This review sheds light on HCC development in the human body. Afterward, we outline various types of biosensors (optical, electrochemical, and mass-based), as well as the most relevant studies of biosensing modalities for non-invasive monitoring of AFP. The review also explains these sensing platforms, detection substrates, surface modification agents, and fluorescent probes used to develop such biosensors. Finally, the challenges and future trends in routine clinical analysis are discussed to motivate further developments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Hepatocellularalpha-FetoproteinsLiver NeoplasmsBiosensing TechniquesEarly Detection of CancerHumansBiomarkers, Tumor

Stichwörter der Autor:innen

alpha-fetoproteinbiosensorsdiagnostic toolsearly detectionhepatocellular carcinoma

Substanzen

alpha-FetoproteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Microfluidics, Sensors and Diagnostics (μSenD) Laboratory, Centre for Microfluidics, Biomarkers, Photoceutics and Sensors (μBioPS), Department of Biotechnology, Manipal Institute of Technology, Manipal Academy of Higher…
  • College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
  • Lung Health Center Department, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
  • Tissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence (TR&I-Dpt), King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.

ORCID-Profile: Momo Arai, Tariq Makhzoum, Ahmed Yaqinuddin, Khaled Al-Kattan, Abdullah M Assiri, Raja Chinnappan

Zitieren

APA

Ramachandran, L., Abul Rub, F., Hajja, A., Alodhaibi, I., Arai, M., Alfuwais, M., Makhzoum, T., Yaqinuddin, A., Al-Kattan, K., Assiri, A. M., Broering, D. C., Chinnappan, R., Mir, T. A., & Mani, N. K. (2024). Biosensing of Alpha-Fetoprotein: A Key Direction toward the Early Detection and Management of Hepatocellular Carcinoma. Biosensors. https://doi.org/10.3390/bios14050235

Vancouver

Ramachandran L, Abul Rub F, Hajja A, Alodhaibi I, Arai M, Alfuwais M, et al. Biosensing of Alpha-Fetoprotein: A Key Direction toward the Early Detection and Management of Hepatocellular Carcinoma. Biosensors. 2024. doi:10.3390/bios14050235

BibTeX
@article{Ramachandran2024,
  author = {Ramachandran, Lohit and Abul Rub, Farah and Hajja, Amro and Alodhaibi, Ibrahim and Arai, Momo and Alfuwais, Mohammed and Makhzoum, Tariq and Yaqinuddin, Ahmed and Al-Kattan, Khaled and Assiri, Abdullah M and Broering, Dieter C and Chinnappan, Raja and Mir, Tanveer Ahmad and Mani, Naresh Kumar},
  title = {Biosensing of Alpha-Fetoprotein: A Key Direction toward the Early Detection and Management of Hepatocellular Carcinoma},
  journal = {Biosensors},
  year = {2024},
  doi = {10.3390/bios14050235}
}
Kostenlos starten →